Skip to main content
. 2015 Mar 27;4:55–63. doi: 10.1007/s40204-015-0037-z

Table 2.

Organ drug distribution from various formulations

Time (h) Percent dose recovered
Liver Kidney Lung Spleen
Rifampicin drug solution 2 24.3 ± 0.3 7.5 ± 0.2 3.6 ± 0.7 2.4 ± 0.3
4 32.7 ± 0.5 8.8 ± 0.7 4.9 ± 0.4 3.2 ± 0.2
6 23.1 ± 0.2 6.5 ± 0.6 2.9 ± 0.4 1.6 ± 0.5
24 7.6 ± 0.5 3.1 ± 0.2 Nil Nil
Uncoupled SLNs 2 28.4 ± 1.2 5.7 ± 0.4 7.1 ± 0.3 6.4 ± 0.5
4 34.8 ± 1.6 6.4 ± 0.2 15.6 ± 0.6 7.3 ± 0.2
6 30.5 ± 1.4 4.3 ± 0.1 6.5 ± 0.2 5.2 ± 0.3
24 18.4 ± 1.5 Nil 2.1 ± 0.5 4.6 ± 0.6
Coupled SLNs 2 33.7 ± 1.2 4.5 ± 0.4 39.3 ± 0.5 7.1 ± 0.1
4 35.5 ± 1.3 5.2 ± 0.6 47.7 ± 0.4 7.6 ± 0.3
6 31.6 ± 0.8 3.4 ± 0.3 42.1 ± 0.4 5.2 ± 0.6
24 22.4 ± 1.5 Nil 35.3 ± 0.2 2.5 ± 0.2

SD ±  mean (n = 3)